Medicare Panel Finds Little Evidence To Support New ECG Technologies
This article was originally published in The Gray Sheet
Executive Summary
Electrocardiogram-based signal analysis tests are designed to be better at detecting coronary artery disease than standard 12-lead ECGs. But more research is needed to show that the technology improves patient health outcomes, MedCAC concludes.